Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Novartis
Company Monitoring Page for Novartis
latest headlines for company on cafepharma
Daily Malaria Drug Matches Twice-a-Day Novartis Pill
Bloomberg
Fri, 04/23/10 - 07:46 am
Tags:
Novartis
,
malaria
,
Coartem
,
Shin Poong
,
South Korea
Will AspenBio Pharma Follow in Dendreon and Human Genome Sciences' Footsteps?
Seeking Alpha
Thu, 04/22/10 - 07:30 am
Tags:
AspenBio
,
Novartis
,
Human Genome Sciences
,
Dendreon
Novartis kidney-transplant drug is cleared by FDA
Marketwatch
Thu, 04/22/10 - 06:43 am
Tags:
Novartis
,
FDA
,
kidney transplant
,
Zortress
Proteus raises $25M, gets FDA clearance
Bizjournals.com
Wed, 04/21/10 - 10:53 am
Tags:
FDA
,
Proteus Biomedical
,
Novartis
New Novartis chief talks productivity
Fierce Pharma
Wed, 04/21/10 - 10:25 am
Tags:
Novartis
,
reorganization
,
Joe Jimenez
,
Pharma CEOs
Better, Targeted Drugs, Dead Ahead
Motley Fool
Wed, 04/21/10 - 07:53 am
Tags:
personalized medicine
,
Vectibix
,
Amgen
,
Novartis
,
Bristol-Myers Squibb
,
Eli Lilly
,
OSI Pharmaceuticals
,
ONYX Pharmaceuticals
,
Roche
Novartis Earnings Rise 49%
TheStreet.com
Tue, 04/20/10 - 09:01 am
Tags:
earnings
,
Novartis
Novartis' Blood-Pressure Drug Tekturna: A Victim of Bad Timing
BNET Pharma
Tue, 04/20/10 - 09:00 am
Tags:
Novartis
,
Tekturna
Novartis expands generics portfolio with Oriel buy
Fierce Pharma
Mon, 04/19/10 - 11:33 am
Tags:
Novartis
,
Oriel
,
generics
,
M&A
Human Genome Sciences' partner Novartis pulls European application for hepatitis C drug
Yahoo/AP
Mon, 04/19/10 - 11:08 am
Tags:
Human Genome Sciences
,
Novartis
,
Joulferon
,
Europe
,
hepatitis C
Those FDA Warning Letters To Glaxo & Novartis
Pharmalot
Mon, 04/19/10 - 11:05 am
Tags:
FDA
,
warnings
,
GSK
,
Novartis
,
Arzerra
,
Vesicare
,
Astellas
,
Voltaren
Novartis Races to Be First With Oral MS Drug
Seeking Alpha
Mon, 04/19/10 - 10:57 am
Tags:
Novartis
,
multiple sclerosis
,
MS
,
Biogen Idec
,
Merck
Novartis initiates second phase-I trial for oral PTH1-34 to treat postmenopausal osteoporosis
Pharmabiz
Sat, 04/17/10 - 12:53 pm
Tags:
Novartis
,
Emisphere
,
Eligen Technology
,
PTH1-34
,
osteoporosis
Novartis Reorganizes US Operations, CEO Leaves
Pharmalot
Wed, 04/14/10 - 02:02 pm
Tags:
Novartis
,
reorganization
Popular Anticonvulsants Raise Suicide Risks: Study
Pharmalot
Wed, 04/14/10 - 09:08 am
Tags:
suicide
,
anticonvulsants
,
Pfizer
,
Neurontin
,
GSK
,
Lamictal
,
Novartis
,
Trileptal
,
Gabitril
,
Cephalon
,
Sanofi
,
Epilim
,
Abbott Laboratories
,
Depakote
Bayer gains on renewed Novartis bid talk
Reuters
Tue, 04/13/10 - 10:06 am
Tags:
Novartis
,
Bayer
,
M&A
Novartis moves closer to first oral MS treatment
Reuters
Tue, 04/13/10 - 09:58 am
Tags:
Novartis
,
MS
,
multiple sclerosis
,
Gilenia
[video]Healthy Growth Prospects for This Pharma Pick
Yahoo/Morningstar
Mon, 04/12/10 - 04:52 pm
Tags:
Novartis
Novartis Sex-Discrimination Case: The Horrible Downside of Tolerating "Bad Apples"
BNET Pharma
Mon, 04/12/10 - 09:44 am
Tags:
Novartis
,
discrimination
Paper: Roche, Novartis threaten to leave UK
Fierce Pharma
Mon, 04/12/10 - 09:42 am
Tags:
UK
,
Roche
,
Novartis
Pages
« first
‹ previous
…
153
154
155
156
157
158
159
160
161
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.